Biotalys NV (BTLS) Stock Price & News

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	3.38M	3.38M	3.08M	3.08M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.31M	1.31M	1.34M	1.34M
Operating expense	3.86M	3.86M	3.60M	3.60M
Total operating expenses	3.86M	3.86M	3.60M	3.60M
Operating income	-3.86M	-3.86M	-3.60M	-3.60M
Other non operating income	-11.50K	-11.50K	500.00	500.00
EBT including unusual items	-3.85M	-3.85M	-4.56M	-4.56M
EBT excluding unusual items	-3.85M	-3.85M	-3.59M	-3.59M
Income tax expense	-35.00K	-35.00K	10.00K	10.00K
Effective tax rate	0.91%	0.91%	-0.22%	-0.22%
Other operating expenses	-832.00K	-832.00K	-822.50K	-822.50K
Net income	-3.81M	-3.81M	-4.57M	-4.57M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	54.50K	54.50K	34.50K	34.50K
Interest expense	-	-	-27.00K	-27.00K
Net interest expenses	54.50K	54.50K	7.50K	7.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	-3.60M	-3.60M	-3.33M	-3.33M
Gain or loss from assets sale	-	-	-	-

Ask anything